Cite
MLA Citation
Austin Duffy et al.. “Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC).” Journal for immunotherapy of cancer, vol. 2, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100135549425.0x000003